Healthcare Market Intelligence
AI adoption moves from pilot to scale as workforce and reimbursement pressure reshape provider economics
Healthcare AI adoption moved from experimentation to scaled deployment in Q2 2026, with health systems prioritizing measurable ROI, workflow integration, and clinician validation over pilot programs. At the same time, labor shortages and reimbursement uncertainty kept pressure on provider margins, pushing operators toward workforce redesign and lower-cost care settings. This report examines how these dynamics are shaping valuations, deal activity, and capital flows across healthcare.
Q2 2026 Report
What's Inside
- How clinical AI, revenue cycle automation, and care navigation are moving from pilot to scaled deployment
- What's driving continued migration toward outpatient, home-based, and lower-cost care settings
- Which healthcare sub-sectors are holding valuation premiums and where compression is emerging
- How workforce and administrative cost pressures are showing up in provider margins
- Why hospital and health system deal count continued to decline and where buyers remain selective
- Where digital health venture funding concentrated this quarter and what it signals for valuations
- How Medicaid, ACA, and reimbursement uncertainty are affecting provider economics
- What rising denials and delayed collections mean for revenue cycle priorities
Download the Report
Q2 2026 Healthcare Quarterly Update
By downloading you’ll also receive future quarterly Healthcare reports and relevant market insights from Houlihan Capital. Unsubscribe anytime.
Our Experience
Healthcare Expertise
Houlihan Capital has served healthcare businesses and investors for over 25 years, providing specialized valuation and transaction advisory services across medical practices, healthcare technology companies, and life sciences organizations. Our team understands the unique regulatory, operational, and financial dynamics that drive success in healthcare markets.
Healthcare Services:
Practice Valuations | Fairness Opinions | Transaction Advisory | Physician Practice Management Support | Healthcare M&A Analysis
Questions? Contact our healthcare specialists at info@houlihancapital.com or 312.450.8600
This content is for informational purposes only and does not constitute investment or medical advice.
More from Houlihan Capital
Explore Related Quarterly Reports
Venture Capital | Q1 2026
Valuation trends, fundraising activity, and exit dynamics across the venture capital ecosystem
Cannabis | Q1 2026
Regulatory developments, wholesale pricing trends, and M&A consolidation across state markets
Business Services | Q1 2026
AI-native delivery, consolidation trends, and valuation dispersion across business services
